Merck announced that it has reached an agreement to sell its 108-acre campus in Kenilworth, N.J., to Onyx Equities. "Merck will vacate the property in phases over the next several years while its new headquarters in Rahway, N.J. completes a planned expansion. As the birthplace of the company in the U.S., the Rahway campus has seen the start of many of Merck’s greatest scientific breakthroughs. Over its 120-year legacy, the site has grown from one manufacturing plant to more than 200 acres focused on discovery and development," the company stated. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRK:
- Merck’s Keytruda with chemotherapy shows improvements in Phase 3 trial
- AstraZeneca, Merck present final results from Phase III PROpel trial
- Merck, AstraZeneca present final results from Phase 3 PROpel trial
- Truist biotechnology analyst to hold an analyst/industry conference call
- Merck price target raised to $125 from $120 at Credit Suisse